» Articles » PMID: 30482313

Parkinson Disease

Overview
Publisher Elsevier
Specialty Neurology
Date 2018 Nov 29
PMID 30482313
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson disease (PD) is a complex, multisystem disorder with both neurologic and systemic nonmotor manifestations. It is neurodegenerative in nature in which disordered balance, gait, and falls are universal problems that can be present at initial diagnosis, and which progress over time. Freezing of gait is a particularly debilitating feature of PD that becomes more prevalent over time with disease progression, being present in approximately 7% after 2 years of disease and 28% after 5 years. Approximately 60% of people with PD fall each year, with around 70% of fallers falling recurrently, and some recurrent fallers falling multiple times per week. Many risk factors for falls in people with PD have been identified; these include a history of falls, freezing of gait, and abnormalities in measures of balance, leg muscle strength, mobility, cognition, and fear of falling. Therapies for improving physical function and mobility include levodopa, cholinesterase inhibitors, methylphenidate, deep-brain stimulation, cuing for freezing of gait, and exercise. This chapter reviews the clinical, pathologic, and physiologic correlates of gait disturbance and falls in PD, as well as the evidence for medical and nonmedical interventions.

Citing Articles

Influence of parkinson's disease on complications and revisions in total hip and knee arthroplasty: insights from a matched pair analysis.

Holzapfel D, Kappenschneider T, Schuster M, Pagano S, Azar F, Holzapfel S Int Orthop. 2025; 49(3):559-572.

PMID: 39856201 PMC: 11889065. DOI: 10.1007/s00264-024-06398-9.


Effects of transcranial direct current stimulation (tDCS) associated with balance training in individuals with Parkinson's: Study protocol for a randomized clinical trial.

Santos R, Areas G, Areas F, Baptista P, Mendonca A, Freire Junior R MethodsX. 2024; 13:103014.

PMID: 39676837 PMC: 11638652. DOI: 10.1016/j.mex.2024.103014.


Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models.

Hertz N, Chin R, Rakhit R, Ditsworth D, Wang C, Bartholomeus J Res Sq. 2024; .

PMID: 38765977 PMC: 11100876. DOI: 10.21203/rs.3.rs-4356493/v1.


Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson's Disease.

Ravenhill S, Evans A, Crewther S Antioxidants (Basel). 2023; 12(5).

PMID: 37237983 PMC: 10215182. DOI: 10.3390/antiox12051117.


Clinicopathologic Characteristics of Melanoma in Patients with Parkinson Disease.

Flynn M, Robinson C, Patel S, Liu B, Green C, Pavlis M JID Innov. 2023; 3(2):100173.

PMID: 36876218 PMC: 9982327. DOI: 10.1016/j.xjidi.2022.100173.